Immune-MRD status informs tumor-MRD outcome prognostication in multiple myeloma patients on lenalidomide maintenance Meeting Abstract
| Authors: | Firestone, R. S.; Simhal, A. K.; McAvoy, D.; Jurgens, E. M.; GarceĢs, J. J.; Nemirovsky, D.; Derkach, A.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; Shah, U. A.; Tan, C. R.; Korde, N.; Hassoun, H.; Rajeeve, S.; Hashmi, H.; Landau, H. J.; Scordo, M.; Shah, G. L.; Giralt, S.; Diamond, B.; Maura, F.; Hosszu, K. K.; Chung, D. J.; Landgren, O.; Usmani, S. Z.; Lesokhin, A. M. |
| Abstract Title: | Immune-MRD status informs tumor-MRD outcome prognostication in multiple myeloma patients on lenalidomide maintenance |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 672 |
| End Page: | 673 |
| Language: | English |
| ACCESSION: | WOS:001415676400021 |
| DOI: | 10.1182/blood-2024-206646 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work